In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on OpGen (OPGN – Research Report), with a price target of $4.00. The company’s shares closed last Thursday at $0.91, close to its 52-week low of $0.78.
According to TipRanks.com, Chen is a 5-star analyst with an average return of 19.0% and a 37.3% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics.
Currently, the analyst consensus on OpGen is a Moderate Buy with an average price target of $4.00.
Based on OpGen’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.24 million and GAAP net loss of $6.06 million. In comparison, last year the company earned revenue of $1.06 million and had a GAAP net loss of $7.68 million.
Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OPGN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
Read More on OPGN:
- Analysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN), Glaukos (GKOS) and Anavex Life Sciences (AVXL)
- Wall Street Analysts Are Bullish on Top Technology Picks
- PepsiCo Falls 2% Despite Exceeding Q4 Expectations, Cites Inflationary Pressures
- H.C. Wainwright Thinks Flux Power Holdings’ Stock is Going to Recover
- H.C. Wainwright Keeps Their Buy Rating on Super League Gaming (SLGG)